Related Experiment Video
Updated: Aug 23, 2026

Time-lapse Imaging of Primary Preneoplastic Mammary Epithelial Cells Derived from Genetically Engineered Mouse Models of Breast Cancer
Published on: February 8, 2013
Brca1 inactivation induces p27(Kip1)-dependent cell cycle arrest and delayed development in the mouse mammary gland
Andrew J Deans1, Kaylene J Simpson, Melanie K Trivett
1Molecular Oncology Laboratory, Trescowthick Research Laboratories, Peter MacCallum Cancer Centre, St Andrew's Place, East Melbourne 3002, Australia.
Abstract:
One common characteristic of breast cancers arising in carriers of the predisposition gene BRCA1 is a loss of expression of the CDK inhibitor p27(Kip1) (p27), suggesting that p27 interacts epistatically with BRCA1. To investigate this relationship, we examined expression of p27 in mice expressing a dominant negative allele of Brca1 (MMTV-trBr) in the mammary gland. While these mice rarely develop tumors, they showed a 50% increase in p27 protein and a delay in mammary gland development associated with reduced proliferation. In contrast, on a p27 heterozygote background, MMTV-trBrca1 mice showed an increase in S phase cells, and normal mammary development. p27 was the only protein in the cyclin-cyclin-dependent kinase network to show altered expression, suggesting that it may be a central mediator of cell cycle arrest in response to loss of function of BRCA1. Furthermore, in human mammary epithelial MCF7 cells expressing BRCA1-specific RNAi and in the BRCA1-deficient human tumor cell line HCC1937, p27 is elevated at the mRNA level compared to cells expressing wild-type BRCA1. We hypothesize that disruption of BRCA1 induces an increase in p27 that inhibits proliferation. Accordingly, reduction in p27 expression leads to enhancement of cellular proliferation in the absence of BRCA1.
Insights
Loss of BRCA1 function in breast cancer may increase p27 protein levels, inhibiting cell proliferation. Reducing p27 enhances proliferation in BRCA1-deficient cells, revealing a key cell cycle regulation mechanism.
Area of Science:
- Oncology
- Cell Biology
- Genetics
Background:
- BRCA1 gene mutations are linked to hereditary breast cancer.
- Loss of p27(Kip1) (p27) expression is common in BRCA1-related breast cancers.
- This suggests a potential functional link between BRCA1 and p27.
Purpose of the Study:
- To investigate the epistatic interaction between BRCA1 and p27.
- To determine if BRCA1 loss-of-function affects p27 expression and cell cycle control.
- To explore the role of p27 as a mediator of cell cycle arrest in BRCA1-deficient cells.
Main Methods:
- Examined p27 expression in mice with a dominant-negative Brca1 allele (MMTV-trBr).
- Assessed p27 heterozygote effects on MMTV-trBrca1 mice mammary development and cell proliferation.
- Analyzed p27 mRNA and protein levels in human breast cancer cells (MCF7, HCC1937) with altered BRCA1 status (RNAi, deficiency).
Main Results:
- MMTV-trBr mice showed increased p27 protein, delayed mammary development, and reduced proliferation.
- In p27 heterozygote MMTV-trBrca1 mice, increased S phase cells and normal mammary development were observed.
- p27 was the sole altered protein in the cyclin-cyclin-dependent kinase network.
- Human cells with BRCA1 disruption (RNAi or deficiency) exhibited elevated p27 mRNA levels.
Conclusions:
- Disruption of BRCA1 function induces an increase in p27, which acts to inhibit cellular proliferation.
- p27 appears to be a central mediator of cell cycle arrest in response to BRCA1 loss.
- Reducing p27 levels enhances proliferation in the absence of functional BRCA1, highlighting its critical role in cell cycle regulation.
Related Concept Videos
Inhibition of Cdk Activity
Negative Regulator Molecules
Abnormal Proliferation
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
